A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EP / etoposide and cisplatin

[Related PubMed/MEDLINE]
Total Number of Papers: 121
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EP  (>> Co-occurring Abbreviation)
Long Form:   etoposide and cisplatin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: a systematic review and network meta-analysis. CIs, GP, HR, NSCLC, OR, OS, PC, PFS, PP, RCTs, SAEs, SP, UP
2019 Delivery of chemotherapy for testicular cancer in routine practice: A population-based study. BEP
2019 HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer. AE, DMFS, LRFS, NSCLC, OS, PFS
2019 Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer. IP, SCLC
2018 Advanced small cell carcinoma of the cervix - Successful treatment with concurrent etoposide and cisplatin chemotherapy and extended field radiation: A case report and discussion. CCRT, EBRT, SCCC
2018 Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer. CRT, LS-SCLC, PFS, TRT
2018 Irinotecan plus cisplatin compared with etoposide plus cisplatin in patients with previously untreated extensive-stage small cell lung cancer: A meta-analysis. CI, DCR, E-SCLC, IP, ORR, RCTs, RR
2018 Neuroendocrine carcinoma of the gastric stump: A case report and literature review. ---
2018 [Conversion Surgery after Etoposide/Cisplatin(EP)Therapy for Huge Pancreatic Neuroendocrine Carcinoma - A Case Report]. NEC
10  2018 [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia]. CO, EMA, FIGO, GTN, MAC
11  2018 [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia]. ActD, EMA, FAEV, FAV, GTN
12  2018 [Metachronous Development of Mantle Cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular Cancer]. CT, LNs, sIL-2R
13  2017 A Study of Patients with Primary Mediastinal Germ Cell Tumors Treated Using Multimodal Therapy. BEP, PMGCTs
14  2017 A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors. CS, GCTs, IGCCCG, NSGCTs, OS, RF, RFS
15  2017 Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses. CI, EC, IC, IP, OR
16  2017 Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial. NSCLC, OS, PC
17  2017 Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer. SCLC
18  2017 Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer. HR, OS, PC, PFS, VP
19  2017 Treatment Outcome in Patients with Primary Central Nervous System Germ Cell Tumour: Clinical Experience from a Regional Cancer Centre in North India. BEP, OS, PFS
20  2017 [Analysis of Efficacy of Surgical Treatment for IIIa Small Cell Lung Cancer]. SCLC, TNM
22  2016 Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial. BP, ES-SCLC, OS, PFS, PR, RR, SD
23  2016 Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. DP, HR, LA-NSCLC
24  2016 Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer. ED-SCLC, OS
25  2016 Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). AUC, HeCOG, RFR
26  2016 Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells. HDAC, SCLC, TS
27  2015 Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma. IP, P-NEC
28  2015 Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. CP, HR
29  2015 Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial. ES-SCLC, IP
30  2015 Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma. CR, DSI, LSI, NACT, OS, SCNEC
31  2015 Modified one-day etoposide and cisplatin combination for previously untreated extensive-disease small-cell lung cancer: A retrospective evaluation of 36 cases. CI, ED-SCLC, OS, PFS
32  2015 Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. IT
33  2015 Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer. E-SCLC, IP, PFS
34  2015 Utilization of sperm banking and barriers to its use in testicular cancer patients. BEP
35  2015 [A Case of Advanced Seminoma in a 79-Year-Old Man Successfully Treated with Etoposide and Cisplatin]. FN
36  2014 A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer. DLT, G-CSF, SCLC
37  2014 Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients. DFS, FIGO, OS, SCCC
38  2014 Etoposide-cisplatin alternating with vinorelbine-cisplatin versus etoposide-cisplatin alone in patients with extensive disease combined with small cell lung cancer. EP-NP
39  2014 MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. MALDI-TOF, SCLC, SNPs
40  2014 Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. CI, GI, HBP, HR, IP, NEC, OS
41  2013 Distal humerus as delayed site of metastasis from small cell carcinoma of gallbladder. SCC
42  2013 Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen. CI, CR, ES-SCLC, OS, PFS, PR
43  2013 Platinum-based chemotherapy for variant castrate-resistant prostate cancer. CD, CEA, CI, OS, SCPC
44  2013 Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma. HDR-BT, NSE, PSA, SCC
45  2013 [A randomized controlled study of chemotherapy: etoposide combined with oxaliplatin or cisplatin regimens in the treatment of extensive-stage small cell lung cancer in elderly patients]. EO, SCLC
46  2012 Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study. C-SCLC, OS, PFS, RR
47  2012 Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer? DM, PS, SCLC
48  2012 Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer. CI
49  2012 Successful treatment of mediastinal seminoma in a hemodialysis patient. GCTs
50  2010 A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. CI, HR, IP
51  2010 Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. IP, LS-SCLC, TRT
52  2010 Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma. G-CSF, IP, SCLC
53  2010 [A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report]. INF, LSCLC, OS, PCI, TRT
54  2009 Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. E-SCLC, IP, PG
55  2009 [Comparison of Oral Topotecan/Intravenous Cisplatin (TC) with Intravenous Etoposide/Cisplatin (EP) as First Line Chemotherapy in Untreated Small Cell Lung Cancer Patient.]. TC
56  2009 [Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review.]. CBM, CJFD, CSJD, IP, SCLC
57  2007 Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. BTOC, CAV, i.v, SCLC
58  2007 Safety of irinotecan/cisplatin versus etoposide/cisplatin for patients with extensive-stage small-cell lung cancer: a metaanalysis. CI, IP, RR
59  2007 [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia]. GTN
60  2006 A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer. IP, PFS, SCLC
61  2006 Extrapulmonary small cell carcinoma--a medical center's experience. CR, DFS, ED, EPSCC, LD, OS, PR
62  2006 Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations. IP, LD, SCLC
63  2006 Irinotecan plus cisplatin compared with etoposide plus cisplatin for small cell lung cancer: a randomized clinical trial. IP, SCLC
64  2006 Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902. IP, IPE, LD-SCLC, TRT
65  2006 Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. GP, NSCLC
66  2006 Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. IP, SCLC
67  2006 Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer. ---
68  2006 [Modified chemotherapy regimens in selected testicular cancer patients with good prognosis]. NSGCT
69  2005 Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors. GCT, IGCCCG
70  2005 One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumor of the testis. BEP
71  2005 Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer. CCRT, CR, i.v, IP, LD-SCLC, PFS, PR, SCLC, TDTRT
72  2005 Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903. IP, JCOG, LSCLC, SCLC, TRT
73  2005 Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). CEV, SCLC
74  2004 Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. FEV1, PFT, RT
75  2004 Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. NSGCT
76  2004 Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience. IP, IPE, SCLC
77  2003 Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. CHT, LSCLC, RT
78  2003 Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer. NSCLC
79  2002 Anemia in oncology practice: relation to diseases and their therapies. CEOP, CMF, FAC
80  2002 Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. CEV, ED, LD, SCLC
81  2002 Concurrent Etoposide/Cisplatin Combination Chemotherapy (EP) and Thoracic Radiotherapy after Two Cycles of EP for Limited Stage Small Cell Lung Cancer. TRT
82  2002 Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study. HOG, SCLC
83  2002 Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. GCTs, hCG-beta, ICE, IMT/G
84  2002 Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. NSCLC, RT
85  2001 A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer. AC, DFS, OS
86  2001 Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. PCDE, SCLC
87  2001 Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. CAV, LSCLC, PCI
88  2001 [A giant testicular tumor detected with dyspnea due to lung metastases: a case report]. CR, LDH, PR, VATS
89  2000 [Etoposide and cisplatin for non-small cell lung cancer: trial at the Soroka Medical Center 1986-1994]. NSCLC
90  1999 The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. CAV, LSCLC, TI
91  1998 Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. CAV, LSCLC
92  1998 Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. AFP, BEP, beta-hCG, BOP, CI, CR, EORTC, MRC, NSGCTs
93  1998 New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. i.v, SCLC
94  1998 Testicular cancer. RPLND
95  1998 [Chemotherapy of disseminated germ cell tumors]. BEP, GCTs, HDCT
96  1997 A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer. ---
97  1997 Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. BEP
98  1997 Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin. CR, GCT, IR
99  1997 ["State-of-the-art" chemotherapy for small-cell lung cancer]. ED, LD, SCLC
100  1996 Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung. CAVE, CR, PCI, PR, REGR, TRT